Publications in collaboration with researchers from Institut d'Investigacions Biomèdiques August Pi i Sunyer (1)

2020

  1. Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)

    Lung Cancer, Vol. 150, pp. 62-69